Breast Cancer Clinical Trials in Rotterdam, South Holland
2 recruitingRotterdam, South Holland, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Not Applicable
Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
Breast CancerCardiotoxicity
Erasmus Medical Center32 enrolled1 locationNCT06622954